Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients.
Chaiho JeongHee-Je KimSeok LeeMoo Il KangJeonghoon HaPublished in: International journal of endocrinology (2020)
Denosumab improved bone mineral density in haematopoietic stem cell transplantation recipients. The use of denosumab could be a good therapeutic option without causing severe adverse effects in recipients of haematopoietic transplantation.